Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinial Trials

- PMLiVE

Lynparza scores another positive phase 3 prostate cancer study

In specific mutations, risk of death was reduced by 66%

- PMLiVE

Avanir’s week goes from bad to worse with Alzheimer’s stumble

Suffers a blow as second phase 3 trial misses the mark

- PMLiVE

J&J’s Invokana gets lifeline with new kidney disease approval

Sales have been down since drug was linked to amputation risk

- PMLiVE

Transformation in healthcare professionals’ digital behaviours

How HCPs use digital technology – and how to understand their behaviours

- PMLiVE

WebMD set to acquire Aptus Health

Transaction includes Aptus' Univadis, EngagedMedia and Tomorrow Networks

- PMLiVE

Four Health in the Top 10!!

Creative Healthcare Agencies

Four Agency Worldwide

- PMLiVE

Johnson pledges £200m cash injection into UK’s life sciences sector

UK-based entrepreneurs “share his ambition”, says industry leader

- PMLiVE

GSK’s Zejula challenges AZ/Merck’s Lynparza in PARP inhibitor category

New data in ovarian cancer creates potential for market battle

- PMLiVE

Hancock says UK will consider mandatory vaccinations

Conservatives' also announce £13bn investment for hospitals over next decade

- PMLiVE

BMS plugs on with Opdivo plus Yervoy in first-line NSCLC

Could be an alternative treatment option to chemotherapy

It’s the guns, stupid

Gun violence in the US – a public health issue – can be better understood through three points

Spotlight interview: 15 minutes on healthcare advertising

Marie Little, Managing Director, OPEN Health Patient & Brand Communications takes 15 minutes to answer some key questions on healthcare advertising

OPEN Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links